Michael P. Smith
Net Worth

Last updated:

What is Michael P. Smith net worth?

The estimated net worth of Mr. Michael P. Smith is at least $6,207,590 as of 7 Sep 2025. He owns shares worth $37,005 as insider, has earned $1,632,735 from insider trading and has received compensation worth at least $4,537,850 in Ingevity Corporation and Zogenix, Inc..

What is the salary of Michael P. Smith?

Mr. Michael P. Smith salary is $736,310 per year as Executive Officer in Ingevity Corporation. He also receives $633,590 as Executive Vice President, Chief Financial Officer & Treasurer in Zogenix, Inc..

How old is Michael P. Smith?

Mr. Michael P. Smith is 64 years old, born in 1961.

What stocks does Michael P. Smith currently own?

As insider, Mr. Michael P. Smith owns shares in one company:

Company Title Shares Price per share Total value
Zogenix, Inc. (ZGNX) Executive Vice President, Chief Financial Officer & Treasurer 1,387 $26.68 $37,005

What does Zogenix, Inc. do?

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

ZGNX logo
ZGNX
Zogenix, Inc.
$26.68

Michael P. Smith insider trading

Zogenix, Inc.

Mr. Michael P. Smith has made 4 insider trades between 2019-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 22,500 units of ZGNX stock on 2 Jan 2020. As of 7 Sep 2025 he still owns at least 1,387 units of ZGNX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 5,218 N/A N/A
Option
Restricted Stock Units 5,218 N/A N/A
Option
Restricted Stock Units 5,218 N/A N/A
Option
Common Stock 5,218 N/A N/A
Option
Restricted Stock Units 3,595 N/A N/A
Option
Restricted Stock Units 3,595 N/A N/A
Option
Common Stock 3,595 N/A N/A
Option
Common Stock 3,595 N/A N/A
Option
Common Stock 22,500 $10.35 $232,875
Sale
Common Stock 22,500 $51.87 $1,166,985
Option
Stock Option (Right to Buy) 22,500 $10.35 $232,875
Option
Stock Option (Right to Buy) 15,000 $10.35 $155,250
Option
Common Stock 15,000 $10.35 $155,250
Sale
Common Stock 15,000 $10.35 $155,250
Option
Common Stock 15,000 $10.35 $155,250
Option
Stock Option (Right to Buy) 15,000 $10.35 $155,250
Sale
Common Stock 15,000 $10.35 $155,250
Option
Stock Option (Right to Buy) 15,000 $10.35 $155,250
Sale
Common Stock 15,000 $10.35 $155,250
Option
Common Stock 15,000 $10.35 $155,250
Option
Restricted Stock Units 1,563 N/A N/A
Option
Common Stock 1,563 N/A N/A

Ingevity key executives

Ingevity Corporation executives and other stock owners filed with the SEC: